Beam Therapeutics Files Annual Report
Ticker: BEAM · Form: ARS · Filed: Apr 17, 2026 · CIK: 0001745999
Sentiment: neutral
Topics: annual-report, sec-filing, biotech
TL;DR
Beam Therapeutics filed its 2025 ARS on 4/17/26. Check it out.
AI Summary
Beam Therapeutics Inc. filed an Annual Report to Security Holders (ARS) on April 17, 2026, for the period ending December 31, 2025. The company, located at 26 Landsdowne Street, Cambridge, MA, is involved in Biological Products. The filing details their operations and financial standing for the fiscal year 2025.
Why It Matters
This filing provides shareholders and potential investors with a comprehensive overview of Beam Therapeutics' performance and strategic direction for the fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine annual report filing and does not contain new material information that would immediately impact risk.
Key Numbers
- 2025-12-31 — Period of Report (Fiscal year end for the ARS filing.)
- 2026-04-17 — Filing Date (Date the ARS was accepted by the SEC.)
Key Players & Entities
- Beam Therapeutics Inc. (company) — Filer
- 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 (address) — Mailing and Business Address
- 0001745999 (company_id) — CIK
- 2836 (industry_code) — SIC Code
FAQ
What is the primary business of Beam Therapeutics Inc. according to this filing?
Beam Therapeutics Inc. is primarily involved in Biological Products, as indicated by its SIC code 2836.
When was the Annual Report to Security Holders (ARS) filed?
The ARS was filed on April 17, 2026.
What period does this ARS filing cover?
This ARS filing covers the period ending December 31, 2025.
Where is Beam Therapeutics Inc. located?
Beam Therapeutics Inc. is located at 26 Landsdowne Street, Cambridge, MA 02139.
What is the CIK number for Beam Therapeutics Inc.?
The CIK number for Beam Therapeutics Inc. is 0001745999.
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 17, 2026 regarding Beam Therapeutics Inc. (BEAM).